Switching beta-blocker therapy in chronic heart failure

International Journal of Cardiology

Volumn 130, Issue 3, 2008, Pages 497-499

  Tomcsányi, János ^a   Wettstein, András ^a   Toldy Schedel, Emil ^a   Somlói, Miklós ^a  

^a Cardiology Department ^*  (Hungary)

Author keywords

Beta blockers; Heart failure; Switching beta blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; CHRONIC DISEASE; HEART FAILURE; HUMANS; METOPROLOL;

EID: 55549137420     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.016     Document Type: Article

References (7)

1. CIBIS-II investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet 353 (1999) 9-13
2. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized interventional trial in congestive heart failure. Lancet 353 (1999) 2001-2007
3. Packer M., Fowler M.B., Roecker E.B., et al. Carvedilol prospective randomized cumulative survival (COPERNICUS) study group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation 106 (2002) 2194-2199
4. Poole-Wilson PA., Swedberg K., Cleland J.G., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with CHF in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet 362 (2003) 7-13
5. Brady A.J., and Poole-Wilson Editorial. ESC-CHF: guidelines for the aspirational and the practical. Heart 92 (2006) 437-440
6. McMurray J., Cohen-Solal A., Dietz R., et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 7 (2005) 710-721
7. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 11 (2005) 1115-1140